[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"healthy-pregnant-women\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:healthy-pregnant-women":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,54],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":24,"conditions":25,"keywords":29,"overallStatus":41,"whyStopped":4,"lastUpdateSubmitDate":42,"lastUpdatePostDateStruct":43,"startDateStruct":46,"completionDateStruct":48,"leadSponsor":50,"locationsCount":53},"100587240","pregnancy-cohort-study-pregnancy-as-a-window-to-future-health-100587240",false,"NCT06925815","Pregnancy Cohort Study: Pregnancy as a Window to Future Health","PregWin","Inclusion Criteria:\n\n* ongoing pregnancy prior to 14th gestational week, women with child wish; above 18 years of age, giving informed consent\n\nExclusion Criteria:\n\n* gestational age \\> 14th week of gestation; below 18 years of age; fetal genetic anomalies \u002Fmalformation",true,"FEMALE","18 Years","50 Years",{"count":21,"type":22},800,"ESTIMATED","OBSERVATIONAL","The goal of this observational cohort study is to gain deep insights into how metabolic disorders such as obesity or diabetes during pregnancy affect the metabolic and cardiovascular health of mother and child in the short and long term.\n\nIt will investigate the following questions:\n\n* How do maternal metabolic disorders affect pregnancy outcomes?\n* How do maternal metabolic disorders affect fetal growth?\n* How do maternal metabolic disorders affect the newborn's metabolism and body composition?\n* How do maternal metabolic disorders during pregnancy affect breast milk composition?\n* How do maternal metabolic disorders during pregnancy affect the metabolic health of the mother after birth? Participants in this study are pregnant women who will be asked to come to the clinics for three visits during their pregnancy, as well as for the delivery of their baby, and one time 2-3 months thereafter. At each visit, researchers will perform physical examinations (such as body composition measurements) and collect biological samples (blood, urine, saliva), clinical information, and lifestyle data. At birth, researchers will collect cord blood and breast milk as well as clinical data of the delivery and the health of the baby. Researchers will measure body fat in newborn babies and at 2-3 months of age.",[26,27,28],"Healthy Pregnant Women","Obese Pregnant Women","Gestational Diabetes",[30,31,32,33,34,35,36,37,38,39,40],"pregnancy","deep phenotyping","maternal metabolism","body composition","longitudinal pregnancy cohort study","fetal growth","obesity in pregnancy","neonatal adiposity","gestational weight gain","gestational diabetes","cardiovascular health","RECRUITING","2026-04-09",{"date":44,"type":45},"2026-04-13","ACTUAL",{"date":47,"type":45},"2023-07-27",{"date":49,"type":22},"2034-06",{"name":51,"class":52},"Medical University of Graz","OTHER",1,{"id":55,"slug":56,"hasResults":11,"nctId":57,"briefTitle":58,"officialTitle":59,"acronym":4,"eligibilityCriteria":60,"healthyVolunteers":16,"sex":17,"minAge":61,"maxAge":62,"enrollmentInfo":63,"targetDuration":4,"studyType":65,"phases":66,"briefSummary":68,"conditions":69,"keywords":4,"overallStatus":41,"whyStopped":4,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":80},"100591434","milk-free-from-a1-type--casein-on-inflammation-gastrointestinal-tolerance-and-pregnancy-outcomes-100591434","NCT06980376","Milk Free From A1-Type β-Casein on Inflammation, Gastrointestinal Tolerance, and Pregnancy Outcomes","Effects of Milk Free From A1-Type β-Casein on Inflammation, Gastrointestinal Tolerance, and Pregnancy Outcomes: A Multi-Centre, Randomised, Open-Label, Prospective Study","Inclusion Criteria:\n\n* 20-35 years of age\n* Recruited at \\\u003C12 weeks of gestation\n* Intention to deliver at study site hospital\n* Singleton pregnancy\n* Able and willing to consume milk during pregnancy\n* Agree not to participate in another interventional clinical study during the present study\n\nExclusion Criteria:\n\n* Body mass index ≥ 35 at enrolment\n* Cow's milk intolerance or allergy\n* Significant systemic disorder (e.g., cardiac, respiratory, endocrinological, hemato-logic, or GI); pre-pregnancy diabetes, hypertension, or other medical conditions that preclude participation per the investigator's judgement\n* Taking any prescribed chronic medications\n* Participation in another clinical trial\n* Investigator uncertainty about the willingness or ability of the participant to comply with the protocol requirements\n* Taking probiotics at screening or two weeks before enrolment\n* Receiving any vaccine at screening or two weeks before enrolment","20 Years","35 Years",{"count":64,"type":22},100,"INTERVENTIONAL",[67],"NA","The aim of the study is to compare the effects of conventional Ultra High Temperature (UHT) milk containing both A1 and A2 type β-caseins (CON) with a2 UHT Milk containing A2 type β-casein only (A1PF) on inflammation, tolerance, and GI symptoms in pregnant women as well as infants' birth outcomes from 12 weeks' gestation up to 40 days post-birth.",[26],"2026-02-04",{"date":72,"type":45},"2026-02-06",{"date":74,"type":45},"2025-08-25",{"date":76,"type":22},"2026-09",{"name":78,"class":79},"a2 Milk Company Ltd.","INDUSTRY",6]